These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment. Chojnowski K, Wawrzyniak E, Treliński J, Niewiarowska J, Cierniewski C. Leuk Lymphoma; 1999 Dec; 36(1-2):77-84. PubMed ID: 10613452 [Abstract] [Full Text] [Related]
3. [Persistent discrepancy between FDP and D-dimer in a patient with acute leukemia]. Sato N, Takahashi H, Nikuni K, Seki Y, Wada K, Tatewaki W, Shibata A. Rinsho Ketsueki; 1995 Mar; 36(3):212-7. PubMed ID: 7783324 [Abstract] [Full Text] [Related]
4. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Spertini O, Callegari P, Cordey AS, Hauert J, Joggi J, von Fliedner V, Schapira M. Blood; 1994 Aug 15; 84(4):1249-56. PubMed ID: 7519478 [Abstract] [Full Text] [Related]
6. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma. Wróbel T, Poreba M, Mazur G, Poreba R, Pyszel A, Beck B, Steinmetz-Beck A, Andrzejak R, Kuliczkowski K. Neoplasma; 2006 Aug 15; 53(3):253-8. PubMed ID: 16652197 [Abstract] [Full Text] [Related]
9. [Atypical defibrination syndromes and acute leukemias with a t(9,22) translocation, apropos of 2 cases]. Meddeb B, Guermazi S, Hafsia R, Ben Abid H, Gouider E, Ben Lakhal R, Bel Haj Ali Z, Ben Othman T, Jeddi R, Dellagi K, Hafsia A. Pathol Biol (Paris); 2001 Apr 15; 49(3):232-6. PubMed ID: 11367558 [Abstract] [Full Text] [Related]
10. [Plasma concentration of the shed form of L-selectin (sL-selectin) in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) and its relation to the clinical course]. Kapelko-Slowik K, Jaźwiec B, Mirosław S, Wołowiec D, Urbaniak-Kujda D, Tomaszewska-Toporska B, Potoczek S, Ciszak L, Kuliczkowski K. Pol Arch Med Wewn; 2004 Nov 15; 112(5):1283-8. PubMed ID: 15773509 [Abstract] [Full Text] [Related]
13. [Clinical significance of the detection of the sL-selectin level in patients with acute leukemia]. Chang JH, Qi ZH, Xu M. Hunan Yi Ke Da Xue Xue Bao; 2002 Apr 28; 27(2):151-3. PubMed ID: 12575346 [Abstract] [Full Text] [Related]
16. Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis. Meissner MH, Zierler BK, Bergelin RO, Chandler WC, Manzo RA, Strandness DE. J Vasc Surg; 2000 Nov 28; 32(5):870-80. PubMed ID: 11054218 [Abstract] [Full Text] [Related]
17. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients? Dincaslan HU, Yavuz G, Unal E, Tacyildiz N, Ikinciogullari A, Dogu F, Guloglu D, Yuksek N, Ertem U. Pediatr Hematol Oncol; 2010 Oct 28; 27(7):503-16. PubMed ID: 20677920 [Abstract] [Full Text] [Related]
19. [Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia]. Aulbert E, Fromm H, Hornemann H. Med Klin (Munich); 1991 Jun 15; 86(6):297-304. PubMed ID: 1886510 [Abstract] [Full Text] [Related]
20. [Acute mixed-cell human leukemia]. Tupitsyn NN. Gematol Transfuziol; 1990 Aug 15; 35(8):18-20. PubMed ID: 2253855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]